STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

JAEB CENTER FOR HEALTH RESEARCH INC: Form 990, tax year 2024

View the entire original 990 at ProPublica ↗

Organization
JAEB CENTER FOR HEALTH RESEARCH INC (EIN 59-3187624)
Tax period
2024-01-01 to 2024-12-31
Filed
2025-04-03
IRS object ID
202520939349301502
Schema version
2024v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2025-04-03T12:55:11-05:00ReturnTs
Tax Period End2024-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN410746749PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CLIFTONLARSONALLEN LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1420 SOUTH ORANGE AVENUE SUITE 900AddressLine1Txt
CityORLANDOCityNm
State AbbreviationFLStateAbbreviationCd
ZIP32801ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2024-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN593187624EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1JAEB CENTER FOR HEALTH RESEARCHBusinessNameLine1Txt
Business Name Line2FOUNDATION INCBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlJAEBBusinessNameControlTxt
Phone8139758690PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line115310 AMBERLY DRIVE 350AddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33647ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonERICA M VOGTPersonNm
Person TitleTREASURERPersonTitleTxt
Phone8139758690PhoneNum
Signature2025-03-31SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd
FieldValueIRS element (for citing)
IRS Responsible Prty Info CurrYes (1)IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonTINA HENTONPreparerPersonNm
PTINP00630282PTIN
Phone4078021200PhoneNum
Preparation2025-03-31PreparationDt
FieldValueIRS element (for citing)
Tax2024TaxYr
Build TS2025-03-06 01:10:19ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerADAM GLASSMANPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line115310 AMBERLY DRIVE 350AddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33647ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$54,183,271GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.JAEB.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1998FormationYr
Legal Domicile StateFLLegalDomicileStateCd
Activity Or MissionDESIGN AND CONDUCT WORLD-CLASS CLINICAL TRIALS AND EPIDEMIOLOGIC RESEARCH.ActivityOrMissionDesc
Voting Members Governing Body5VotingMembersGoverningBodyCnt
Voting Members Independent4VotingMembersIndependentCnt
Total Employee190TotalEmployeeCnt
Total Volunteers4TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$35,083,784PYContributionsGrantsAmt
CY Contributions Grants$32,326,515CYContributionsGrantsAmt
PY Program Service Revenue$17,927,381PYProgramServiceRevenueAmt
CY Program Service Revenue$18,960,490CYProgramServiceRevenueAmt
PY Investment Income$209,814PYInvestmentIncomeAmt
CY Investment Income$325,075CYInvestmentIncomeAmt
PY Other Revenue$0PYOtherRevenueAmt
CY Other Revenue$34,593CYOtherRevenueAmt
PY Total Revenue$53,220,979PYTotalRevenueAmt
CY Total Revenue$51,646,673CYTotalRevenueAmt
PY Grants And Similar Paid$911,714PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$9,698,833CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$18,429,062PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$20,497,067CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$25,547,640PYOtherExpensesAmt
CY Other Expenses$29,973,426CYOtherExpensesAmt
PY Total Expenses$44,888,416PYTotalExpensesAmt
CY Total Expenses$60,169,326CYTotalExpensesAmt
PY Revenues Less Expenses$8,332,563PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$8,522,653CYRevenuesLessExpensesAmt
Total Assets BOY$23,767,716TotalAssetsBOYAmt
Total Assets EOY$21,082,347TotalAssetsEOYAmt
Total Liabilities BOY$19,487,316TotalLiabilitiesBOYAmt
Total Liabilities EOY$25,337,257TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$4,280,400NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY-$4,254,910NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionOUR MISSION IS TO EXPAND SCIENTIFIC KNOWLEDGE AND IMPROVE PUBLIC HEALTH BY DESIGNING AND CONDUCTING WORLD-CLASS CLINICAL TRIALS AND EPIDEMIOLOGIC RESEARCH.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$51,988,513ExpenseAmt
Grant$9,698,833GrantAmt
Revenue$18,960,490RevenueAmt
DescSEE SCHEDULE ODesc
Total Program Service Expenses$51,988,513TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign OfficeYes (1)ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document134IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee190EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members5GoverningBodyVotingMembersCnt
Independent Voting Member4IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of Committees0MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1ERICA VOGTBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone8139758690PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line115310 AMBERLY DRIVE SUITE 350AddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33647ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (13 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
ROY BECK
MEDICAL DIRECTOR40.001.00Yes (X)$503,353$0$120,835
DANA BALL
DIRECTOR1.001.00Yes (X)$0$0$0
NEIL BRESSLER
DIRECTOR1.001.00Yes (X)$0$0$0
ANNE LINDBLAD
DIRECTOR1.001.00Yes (X)$0$0$0
SHAN SHIKARPURI
DIRECTOR1.001.00Yes (X)$0$0$0
ERICA VOGT
CHIEF FINANCIAL OFFICER40.001.00$243,550$0$53,629Yes (X)
ADAM GLASSMAN
PRESIDENT40.001.00$342,541$0$79,366Yes (X)
JEANNIE PERKINS
CHIEF RESEARCH COMPLIANCE40.000.00$192,580$0$44,445Yes (X)
CRAIG KOLLMAN
DIRECTOR OF BIOSTATISTICS40.000.00$251,335$0$59,531Yes (X)
ALLISON AYALA
BIOSTATISTICIAN IV40.000.00$195,142$0$43,879Yes (X)
B MICHELE MELIA
BIOSTATISTICIAN V40.000.00$230,500$0$51,320Yes (X)
PETER CALHOUN
BIOSTATISTICIAN IV40.000.00$210,542$0$50,037Yes (X)
RAYMOND KRAKER
EPIDEMIOLOGIST IV40.000.00$174,001$0$43,879Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,343,544TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$546,921TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K97IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (2 entries)

Address Line1ContractorAddress/ForeignAddress/AddressLine1TxtCityContractorAddress/ForeignAddress/CityNmProvince Or StateContractorAddress/ForeignAddress/ProvinceOrStateNmCountryContractorAddress/ForeignAddress/CountryCdServicesServicesDescCompensationCompensationAmtAddress Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCd
COGNIZANT WORLDWIDE LIMITED
280 BISHOPGATELONDONEC2M4AGUKSOFTWARE DEVELOPMENT$623,750
FEDERAL EXPRESS
SHIPPING SERVICES$514,2083610 HACKS CROSS ROADMEMPHISTN38125
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K6CntrctRcvdGreaterThan100KCnt
Government Grants$19,495,807GovernmentGrantsAmt
All Other Contributions$12,830,708AllOtherContributionsAmt
Total Contributions$32,326,515TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescINDUSTRY PROGRAM SERVICE EXCHANGEDesc
Business541700BusinessCd
Total Revenue Column$18,960,490TotalRevenueColumnAmt
Related Or Exempt Func Income$18,960,490RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$18,960,490TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$241,673TotalRevenueColumnAmt
Exclusion$241,673ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$2,620,000SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$2,536,598SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$83,402SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$83,402TotalRevenueColumnAmt
Exclusion$83,402ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescMISCELLANEOUS INCOMEDesc
Business900099BusinessCd
Total Revenue Column$34,593TotalRevenueColumnAmt
Exclusion$34,593ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$34,593OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$51,646,673TotalRevenueColumnAmt
Related Or Exempt Func Income$18,960,490RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$359,668ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$9,698,833TotalAmt
Program Services$9,698,833ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,580,299TotalAmt
Program Services$489,486ProgramServicesAmt
Management And General$1,090,813ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$16,651,048TotalAmt
Program Services$12,474,871ProgramServicesAmt
Management And General$4,176,177ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$934,319TotalAmt
Program Services$730,031ProgramServicesAmt
Management And General$204,288ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$95,844TotalAmt
Program Services$95,844ProgramServicesAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,235,557TotalAmt
Program Services$884,594ProgramServicesAmt
Management And General$350,963ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$30,819TotalAmt
Management And General$30,819ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$91,591TotalAmt
Management And General$91,591ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$4,229TotalAmt
Management And General$4,229ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$877,892TotalAmt
Program Services$737,455ProgramServicesAmt
Management And General$140,437ManagementAndGeneralAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$14,393TotalAmt
Program Services$12,659ProgramServicesAmt
Management And General$1,734ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$511,197TotalAmt
Management And General$511,197ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$1,011,918TotalAmt
Program Services$172,690ProgramServicesAmt
Management And General$839,228ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$282,335TotalAmt
Management And General$282,335ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,239,636TotalAmt
Program Services$1,157,038ProgramServicesAmt
Management And General$82,598ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$97,495TotalAmt
Management And General$97,495ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$170,917TotalAmt
Management And General$170,917ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
SUBCONTRACTOR PAYMENTS$21,674,686$21,674,686
RESEARCH EXPENSES$3,781,403$3,781,403
TRAINING$41,041$41,041
DUES & SUBSCRIPTIONS$36,682$36,682

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$107,192TotalAmt
Program Services$78,923ProgramServicesAmt
Management And General$28,269ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$60,169,326TotalAmt
Program Services$51,988,513ProgramServicesAmt
Management And General$8,180,813ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$9,063,779BOYAmt
EOY$2,863,735EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$2,633,881BOYAmt
EOY$8,968,703EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$7,699,495BOYAmt
EOY$5,245,794EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$12,138BOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$464,581BOYAmt
EOY$1,472,099EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$1,687,681LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$1,139,099LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$238,450BOYAmt
EOY$548,582EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$2,574,929BOYAmt
EOY$1,067,835EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$1,080,463BOYAmt
EOY$915,599EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$23,767,716BOYAmt
EOY$21,082,347EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$4,597,583BOYAmt
EOY$2,792,914EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$13,768,197BOYAmt
EOY$21,568,416EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,121,536BOYAmt
EOY$975,927EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$19,487,316BOYAmt
EOY$25,337,257EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$4,280,400BOYAmt
EOY-$4,254,910EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$4,280,400BOYAmt
EOY-$4,254,910EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$23,767,716BOYAmt
EOY$21,082,347EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$8,522,653ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$12,657NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$31,738,886CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$24,875,930CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$28,983,474CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$35,083,784CurrentTaxYearMinus1YearAmt
Current Tax Year$32,326,515CurrentTaxYearAmt
Total$153,008,589TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$31,738,886CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$24,875,930CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$28,983,474CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$35,083,784CurrentTaxYearMinus1YearAmt
Current Tax Year$32,326,515CurrentTaxYearAmt
Total$153,008,589TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$8,539,006SubstantialContributorsTotAmt
Public Support Total170$144,469,583PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$59,752CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$2,389CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,171CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$206,410CurrentTaxYearMinus1YearAmt
Current Tax Year$241,673CurrentTaxYearAmt
Total$515,395TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year$34,595CurrentTaxYearAmt
Total$34,595TotalAmt
FieldValueIRS element (for citing)
Total Support$153,558,579TotalSupportAmt
Gross Receipts Rltd Activities$57,907,160GrossReceiptsRltdActivitiesAmt
Public Support CY1700.94080PublicSupportCY170Pct
Public Support PY1700.90780PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$143,971OtherCostOrOtherBasisAmt
Depreciation$14,397DepreciationAmt
Book Value$129,574BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,543,710OtherCostOrOtherBasisAmt
Depreciation$1,124,702DepreciationAmt
Book Value$419,008BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$548,582TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescLEASE LIABILITYDesc
Amt$975,927Amt
FieldValueIRS element (for citing)
Total Liability$975,927TotalLiabilityAmt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES027PROGRAM SERVICESCLINICAL RESEARCH SITES CONTRACTED TO ENROLL PATIENTS AND CONDUCT RESEARCH ACTIVITIES$455,725
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM026PROGRAM SERVICESCLINICAL RESEARCH SITES CONTRACTED TO ENROLL PATIENTS AND CONDUCT RESEARCH ACTIVITIES$1,096,377
MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT,03PROGRAM SERVICESCLINICAL RESEARCH SITES CONTRACTED TO ENROLL PATIENTS AND CONDUCT RESEARCH ACTIVITIES$92,299
EAST ASIA AND THE PACIFIC02PROGRAM SERVICESCLINICAL SITES WHERE PATIENTS ARE ENROLLED IN US-COORDINATED CLINICAL TRIALS.$3,893
SOUTH AMERICA06PROGRAM SERVICESCLINICAL SITES WHERE PATIENTS ARE ENROLLED IN US-COORDINATED CLINICAL TRIALS.$245,685
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees64SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee64TotalEmployeeCnt
Subtotal Spent$1,893,979SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$1,893,979TotalSpentAmt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationTHE ONLY GRANTS OR ASSISTANCE USED OUTSIDE THE US ARE FOR PROGRAM SERVICES (CLINICAL SITES) IN THE CONDUCT OF CLINICAL TRIALS. SUBRECIPIENTS (SITES) OUTSIDE THE US ARE MONITORED USING THE SAME PROCEDURES AS IS REQUIRED FOR SUBRECIPIENTS (SITES) INSIDE THE US.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable

Recipient Business Name RecipientBusinessName

FieldValueIRS element (for citing)
Business Name Line1JAEB CENTER RESEARCH TRUST INCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line115310 AMBERLY DRIVEAddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33647ZIPCd
FieldValueIRS element (for citing)
Recipient EIN270717710RecipientEIN
IRC Section501(C)(3)IRCSectionDesc
Cash Grant$9,698,833CashGrantAmt
Non Cash Assistance$0NonCashAssistanceAmt
Valuation Method UsedN/AValuationMethodUsedDesc
Non Cash AssistanceN/ANonCashAssistanceDesc
Purpose Of GrantGENERAL SUPPORTPurposeOfGrantTxt
FieldValueIRS element (for citing)
Total501c3 Org1Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationJCHR MADE GRANTS ONLY TO ITS OWN RELATED ORGANIZATION.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
ROY BECK
MEDICAL DIRECTOR$503,353$0$0$0$0$0$30,500$0$90,335$0$624,188$0$0$0
ADAM GLASSMAN
PRESIDENT$342,541$0$0$0$0$0$33,241$0$46,125$0$421,907$0$0$0
CRAIG KOLLMAN
DIRECTOR OF BIOSTATISTICS$251,335$0$0$0$0$0$19,335$0$40,196$0$310,866$0$0$0
ERICA VOGT
CHIEF FINANCIAL OFFICER$243,550$0$0$0$0$0$34,550$0$19,079$0$297,179$0$0$0
B MICHELE MELIA
BIOSTATISTICIAN V$230,500$0$0$0$0$0$30,500$0$20,820$0$281,820$0$0$0
PETER CALHOUN
BIOSTATISTICIAN IV$210,542$0$0$0$0$0$32,996$0$17,041$0$260,579$0$0$0
ALLISON AYALA
BIOSTATISTICIAN IV$195,142$0$0$0$0$0$23,000$0$20,879$0$239,021$0$0$0
JEANNIE PERKINS
CHIEF RESEARCH COMPLIANCE$192,580$0$0$0$0$0$23,000$0$21,445$0$237,025$0$0$0
RAYMOND KRAKER
EPIDEMIOLOGIST IV$174,001$0$0$0$0$0$2,512$0$41,367$0$217,880$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 3FormAndLineReferenceDesc
ExplanationTHE BOARD OF DIRECTORS SHALL ANNUALLY REVIEW AND APPROVE THE COMPENSATION OF THE CORPORATE OFFICERS, ANY KEY EMPLOYEES (AS DEFINED BY THE IRS), AND THE NEXT FIVE HIGHEST COMPENSATED EMPLOYEES AS LISTED ON THE ORGANIZATION'S PRIOR YEAR FORM 990. IT IS THE BOARD'S INTENTION THAT THIS POLICY AND ITS ASSOCIATED PROCEDURES WILL MEET THE REBUTTABLE PRESUMPTION TEST UNDER IRC 4958 AND TREASURY REGULATION 53.4958-6. THE PURPOSE OF THE ANNUAL REVIEW IS TO ENSURE THAT THE COMPENSATION PROGRAM FALLS WITHIN A REASONABLE RANGE OF COMPETITIVE PRACTICES FOR COMPARABLE POSITIONS AMONG SIMILARLY SITUATED ORGANIZATIONS. THE BOARD WILL KEEP ROBUST MINUTES OF ITS DELIBERATIONS AND DECISIONS, THE PRESIDENT'S REPORTS, THE CORPORATE TREASURER'S REPORTS, AND ANY OTHER SUPPORTING DOCUMENTATION THAT IT RELIES ON FOR ITS COMPENSATION DECISIONS. ALL THESE DOCUMENTS WILL BE DELIVERED TO THE CORPORATE SECRETARY PROMPTLY AFTER THE BOARD MEETING FOR ENTRY INTO THE CORPORATE BOOKS AND RECORDS.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART III, LINE 4ADURING 2024, JCHR WAS ENGAGED IN 50 CLINICAL STUDIES, WHICH CULMINATED IN 51 SCIENTIFIC PUBLICATIONS AND 50 PRESENTATIONS AT PROMINENT NATIONAL AND INTERNATIONAL CONFERENCES. IN 2024, JCHR RECEIVED GRANTS FROM THE NATIONAL INSTITUTES OF HEALTH (8), HELMSLEY CHARITABLE TRUST (10), BREAKTHROUGH T1D (6), FOUNDATION FIGHTING BLINDNESS (6), CYSTIC FIBROSIS FOUNDATION (5), FOOD AND DRUG ADMINISTRATION (1), AND NATIONAL INSTITUTE FOR HEALTH AND CARE RESEARCH (1). COLLABORATIONS WITH INDUSTRY CONTINUES TO BE AN INTEGRAL PART OF OUR WORK. JCHR WAS ENGAGED IN COLLABORATIONS WITH 14 INDUSTRY PARTNERS SPANNING 21 STUDIES, INCLUDING 9 INVESTIGATOR INITIATED STUDIES. SEVERAL STUDIES ARE FUNDED BY MULTIPLE SOURCES. FOR EXAMPLE, ONE CLINICAL TRIAL EVALUATING FENOFIBRATE FOR DIABETIC RETINOPATHY IS A LARGE COLLABORATION WITH FUNDS PROVIDED BY THE NATIONAL INSTITUTES OF HEALTH (NATIONAL EYE INSTITUTE AND NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASE), BREAKTHROUGH T1D, HELMSLEY CHARITABLE TRUST, AND ROCHE. JCHR ALSO SELF-FUNDED ONE STUDY AND NUMEROUS STATISTICAL ANALYSIS PROJECTS USING DATASETS FROM PREVIOUSLY COMPLETED STUDIES. AMONG APPROXIMATELY 2,845 ENTITIES RECEIVING NIH FUNDING IN 2024, JCHR RANKS IN THE TOP 9 PERCENT. OUT OF APPROXIMATELY 65,000 NIH GRANTS AWARDED IN 2024, JCHR HAD THE 178TH- (TOP 0.3 PERCENT) AND 312TH- (TOP 0.47 PERCENT) LARGEST GRANTS (SOURCE: BLUE RIDGE INSTITUTE FOR MEDICAL RESEARCH, 2024). JCHR'S STUDIES IN 2024 LED TO SEVERAL HIGH-IMPACT FINDINGS WITH CLINICAL AND REGULATORY IMPLICATIONS. NOTABLE RESULTS INCLUDE: DIABETES STUDIES: 1. SECURE-T2D TRIAL RESULTS: THIS STUDY DEMONSTRATED THAT THE OMNIPOD 5 AUTOMATED INSULIN DELIVERY SYSTEM WAS SAFE AND EFFECTIVE FOR ADULTS WITH TYPE 2 DIABETES, HELPING TO OPTIMIZE GLUCOSE CONTROL. THE RESULTS OF THE TRIAL LEAD TO FDA APPROVAL OF OMNIPOD 5 FOR PATIENTS WITH TYPE 2 DIABETES. 2. EVALUATION OF ULTRA-RAPID LISPRO INSULIN WITH CONTROL-IQ TECHNOLOGY: A MULTICENTER STUDY EVALUATED THE USE OF ULTRA-RAPID LISPRO (URLI) INSULIN IN COMBINATION WITH CONTROL-IQ TECHNOLOGY ACROSS ADULTS, ADOLESCENTS, AND CHILDREN WITH TYPE 1 DIABETES. THE RESULTS SHOWED THAT URLI INSULIN IMPROVED POSTPRANDIAL GLUCOSE CONTROL AND ENHANCED OVERALL TIME IN RANGE, HIGHLIGHTING ITS EFFECTIVENESS AS PART OF AN ADVANCED AUTOMATED INSULIN DELIVERY SYSTEM. THIS STUDY LED TO TANDEM DIABETES CARE, INC., OBTAINING EUROPEAN UNION (EU) CLEARANCE FOR THE T:SLIM X2 INSULIN PUMP WITH CONTROL-IQ AUTOMATED INSULIN DELIVERY (AID) TECHNOLOGY WITH THE USE OF ELI LILLY AND COMPANY'S LYUMJEV (INSULIN LISPRO-AABC INJECTION) ULTRA-RAPID-ACTING INSULIN. 3. IMPACT OF CGM ON PREGNANCY OUTCOMES: THE STUDY DEMONSTRATED THAT CONTINUOUS GLUCOSE MONITORING (CGM) WAS COMPARABLE TO ORAL GLUCOSE TOLERANCE TEST FOR DIAGNOSING GESTATIONAL DIABETES AND USEFUL IN PREDICTING ADVERSE PERINATAL OUTCOMES. 4. EXERCISE AND GLUCOSE CONTROL IN TYPE 1 DIABETES (T1DEXI STUDY): THIS RESEARCH SHOWED THAT STRATEGIC EXERCISE COULD REDUCE HYPERGLYCEMIA RISK WITHOUT CAUSING HYPOGLYCEMIA. THE STUDY ALSO REVEALED IMPORTANT SEX DIFFERENCES IN DIABETES SELF-MANAGEMENT STRATEGIES. 5. AUTOMATED INSULIN DELIVERY (AID) FOR OLDER ADULTS: A RANDOMIZED TRIAL FOUND THAT OLDER ADULTS WITH TYPE 1 DIABETES SIGNIFICANTLY BENEFITED FROM AID SYSTEMS, EXPERIENCING IMPROVED GLYCEMIC CONTROL AND ENHANCED QUALITY OF LIFE. 6. INHALED INSULIN PLUS BASAL INSULIN VS. USUAL CARE: A RANDOMIZED TRIAL COMPARED THE EFFECTIVENESS OF INHALED INSULIN COMBINED WITH BASAL INSULIN TO STANDARD CARE IN ADULTS WITH TYPE 1 DIABETES. THE STUDY FOUND THAT THE COMBINATION OF INHALED AND BASAL INSULIN WAS NON-INFERIOR TO STANDARD CARE CONSISTING PREDOMINATELY OF EITHER AN AUTOMATED INSULIN DELIVERY SYSTEM OR MULTIPLE DAILY INSULIN INJECTIONS. THESE FINDINGS HIGHLIGHT THE POTENTIAL FOR INHALED INSULIN AS A VIABLE ALTERNATIVE TO TRADITIONAL RAPID-ACTING INSULIN THERAPY AND TO ENHANCE DIABETES MANAGEMENT STRATEGIES. EYE DISEASE STUDIES: 1. ADVANCED RETINAL IMAGING FOR DIABETIC RETINOPATHY: RESEARCH FROM THE DRCR RETINA NETWORK HIGHLIGHTED THAT LESION TYPES AND THEIR DISTRIBUTION ON ULTRAWIDE FIELD IMAGING ARE ASSOCIATED WITH THE PROGRESSION OF DIABETIC RETINOPATHY, AIDING RISK ASSESSMENT FOR PATIENTS. 2. RETINAL DEGENERATION PROGRESSION: THE RUSH2A STUDY OFFERED KEY FINDINGS ON THE PROGRESSION RATES OF USH2A-RELATED RETINAL DEGENERATION, WHICH WILL GUIDE FUTURE CLINICAL TRIALS IN RARE RETINAL DISEASES. 3. CORNEAL TRANSPLANT RESEARCH: A STUDY ON CULTIVATED AUTOLOGOUS LIMBAL EPITHELIAL CELL (CALEC) TRANSPLANTATION REVEALED IMPROVED CENTRAL CORNEAL STRUCTURE AND FUNCTION IN PATIENTS WITH LIMBAL STEM CELL DEFICIENCY ONE YEAR AFTER TREATMENT.
FORM 990, PART VI, SECTION A, LINE 8BTHERE ARE NO COMMITTEES WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY.
FORM 990, PART VI, SECTION B, LINE 11BA COMPLETE COPY OF FORM 990 INCLUDING ALL SUPPORTING SCHEDULES WILL BE PROVIDED TO THE BOARD OF DIRECTORS AT ITS ANNUAL MEETING FOR REVIEW AND ACCEPTANCE PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12CANY BOARD DIRECTOR, CORPORATE OFFICER, OR MEMBER OF A BOARD COMMITTEE WHO HAS DIRECT OR INDIRECT FINANCIAL INTEREST, AS DEFINED BELOW, IS AN INTERESTED PERSON. IF A PERSON IS AN INTERESTED PERSON WITH RESPECT TO ANY AFFILIATE OR SUBSIDIARY OF THE CORPORATION, HE/SHE IS AN INTERESTED PERSON WITH RESPECT TO THE CORPORATION AND ALL AFFILIATED OR SUBSIDIARY ENTITIES. A CONFLICT OF INTEREST SHALL BE DEEMED TO EXIST AT ANY TIME WHEN AN INTEREST HELD, INCLUDING WITHOUT LIMITATION A FINANCIAL INTEREST, OR RELATIONSHIP MAINTAINED BY AN INTERESTED PERSON, PROHIBITS OR INHIBITS, OR POTENTIALLY PROHIBITS OR INHIBITS, THE INTERESTED PERSON FROM EXERCISING INDEPENDENT JUDGMENT IN THE BEST INTERESTS OF THE CORPORATION. A CONFLICT OF INTEREST SHALL NOT EXIST IF RESULTING SOLELY FROM THE NORMAL CONDUCT OF ACTIVITIES AND BUSINESS BY AND BETWEEN THE CORPORATION OR OTHER AFFILIATES OF THE CORPORATION. AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FACTS AND CIRCUMSTANCES OF ANY CONFLICT OF INTEREST OR CONFLICT OF LOYALTY TO THE APPROPRIATE GOVERNANCE BODY WITH RESPECT TO ANY ACTION OR PROPOSED ACTION THAT GIVES RISE TO A CONFLICT OF INTEREST OR CONFLICT OF LOYALTY. DISCLOSURE MUST BE MADE TO THE BOARD OF DIRECTORS OR THE BOARD OF DIRECTORS COMMITTEE AS APPROPRIATE TO THE CIRCUMSTANCES. AFTER DISCLOSURE OF THE CONFLICT OF INTEREST OR CONFLICT OF LOYALTY AND ALL MATERIAL FACTS RELATED THERETO, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, THE INTERESTED PERSON SHALL LEAVE ANY BOARD OF DIRECTORS OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD DIRECTORS OR COMMITTEE MEMBERS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. IN THE CASE OF A DISCLOSURE TO A COMMITTEE, THE COMMITTEE MAY REFER THE MATTER FOR DECISION TO THE BOARD OF DIRECTORS. PENDING REVIEW AND RESOLUTION BY THE BOARD OF DIRECTORS OR BOARD COMMITTEE, THE INTERESTED PERSON SHALL LEAVE DURING ANY DELIBERATIONS OR ACTION CONCERNING THE MATTER THAT GIVES RISE TO A CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15THE BOARD OF DIRECTORS SHALL ANNUALLY REVIEW AND APPROVE THE COMPENSATION OF THE CORPORATE OFFICERS, ANY KEY EMPLOYEES (AS DEFINED BY THE IRS), AND THE NEXT FIVE HIGHEST COMPENSATED EMPLOYEES AS LISTED ON THE ORGANIZATION'S PRIOR YEAR FORM 990. IT IS THE BOARD'S INTENTION THAT THIS POLICY AND ITS ASSOCIATED PROCEDURES WILL MEET THE REBUTTABLE PRESUMPTION TEST UNDER IRC 4958 AND TREASURY REGULATION 53.4958-6. THE PURPOSE OF THE ANNUAL REVIEW IS TO ENSURE THAT THE COMPENSATION PROGRAM FALLS WITHIN A REASONABLE RANGE OF COMPETITIVE PRACTICES FOR COMPARABLE POSITIONS AMONG SIMILARLY SITUATED ORGANIZATIONS. THE BOARD WILL KEEP ROBUST MINUTES OF ITS DELIBERATIONS AND DECISIONS, THE PRESIDENT'S REPORTS, THE CORPORATE TREASURER'S REPORTS, AND ANY OTHER SUPPORTING DOCUMENTATION THAT IT RELIES ON FOR ITS COMPENSATION DECISIONS. ALL THESE DOCUMENTS WILL BE DELIVERED TO THE CORPORATE SECRETARY PROMPTLY AFTER THE BOARD MEETING FOR ENTRY INTO THE CORPORATE BOOKS AND RECORDS. THE PROCESS DESCRIBED HERE WAS LAST COMPLETED IN 2024.
FORM 990, PART VI, SECTION C, LINE 19THE AUDITED FINANCIAL STATEMENTS, FORM 990S, AND FORM 1023 ARE MADE AVAILABLE TO THE PUBLIC ON THE ORGANIZATION'S WEBSITE AND UPON REQUEST.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1JAEB CENTER RESEARCH TRUST INCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line115310 AMBERLY DRIVEAddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33647ZIPCd
FieldValueIRS element (for citing)
EIN270717710EIN
Primary ActivitiesSUPPORTPrimaryActivitiesTxt
Legal Domicile StateFLLegalDomicileStateCd
Exempt Code Section501(C)(3)ExemptCodeSectionTxt
Public Charity StatusLINE 12B, IIPublicCharityStatusTxt
Direct Controlling NAN/ADirectControllingNACd
Controlled Organization0ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgYes (1)GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (1)SharingOfFacilitiesInd
Paid Employees SharingYes (1)PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp

Other Organization Name OtherOrganizationName

FieldValueIRS element (for citing)
Business Name Line1JAEB CENTER RESEARCH TRUST INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Transaction TypeBTransactionTypeTxt
Involved$9,698,833InvolvedAmt
Method Of Amount DeterminationCASHMethodOfAmountDeterminationTxt